<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hepatic nuclear factor-4alpha (HNF-4alpha), a transcription factor involved in the regulation of serum <z:chebi fb="23" ids="18059">lipid</z:chebi> and <z:chebi fb="105" ids="17234">glucose</z:chebi> levels, has recently been associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The HNF-4alpha gene (HNF4A) resides on chromosome 20q12-q13.1, which, in addition to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, has also previously been linked to high <z:chebi fb="4" ids="17855">triglycerides</z:chebi> in Finnish familial <z:hpo ids='HP_0008356'>combined hyperlipidemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FCHL</z:e>) families </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FCHL</z:e>, characterized by elevated levels of serum total cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, or both, is a common <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> observed in up to 20% of patients with premature <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Considering the clear phenotypic overlap between type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FCHL</z:e>, both predisposing to high serum <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, we tested this gene for association in dyslipidemic families originating from two distinct populations, Finnish and Mexican, and comprising 1,447 subjects </plain></SENT>
<SENT sid="4" pm="."><plain>Our data show that common HNF4A variants and haplotypes are associated with elevated serum <z:chebi fb="23" ids="18059">lipid</z:chebi> levels and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (P = 0.008-0.04), as well as with elevated <z:chebi fb="105" ids="17234">glucose</z:chebi> parameters (P = 0.008-0.03), using family-based association analysis </plain></SENT>
<SENT sid="5" pm="."><plain>Importantly, both Finnish and Mexican families shared two common <z:chebi fb="23" ids="18059">lipid</z:chebi>-associated HNF4A haplotypes (P = 0.005 for total cholesterol and 0.006 for <z:chebi fb="4" ids="17855">triglycerides</z:chebi>) </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, we show for the first time that common HNF4A variants are associated with high serum <z:chebi fb="23" ids="18059">lipid</z:chebi> levels and the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
</text></document>